Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 4, 1995BMJOpen Access

Fortnightly Review: Drug treatment of Parkinson's disease

View Full Paper
Ask AI
Bookmark
Share

Authors

NQN QuinnLancashire Care NHS Foundation Trust

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

N Quinn (1995) studied this question.

synapsesocial.com/papers/6a11d00fa84ddbb210fd4ac8https://doi.org/10.1136/bmj.310.6979.575
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Young onset Parkinson's disease1987 · 445 citations
  2. 2Onset and End-of-Dose Levodopa-Induced Dyskinesias1978 · 92 citations
  3. 3Confusion, dementia and anticholinergics in Parkinson's disease.1982 · 135 citations
  4. 4Transferrin C Subtypes and Myocardial Infarction1993 · 35 citations
  5. 5Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years1993 · 204 citations